Yahoo Web Search

Sign In

Search results

  1. 21.74
    Add to watchlist
    +0.11 (+0.49%)
    At close: Fri. May 24, 2024 3:26 PM EDT · Delayed Quote (USD) · Market closed
    Full chart
    • Open
      21.73
      High
      21.79
      Low
      21.50
    • Mkt Cap
      N/A
      P/E (TTM)
      2.11
      Div & Yield
      1.22 & 5.63%
    • Prev. Close
      21.63
      52 Wk. Low
      19.25
      52 Wk. High
      23.94

    More about PSA-PI

    Related stocks

    More on Yahoo Finance

  2. Flights

    Powered by

  3. finance.yahoo.com › quote › PSA-PIPublic Storage (PSA-PI) Stock Price, News, Quote & History ...

    Open 21.81. Bid 21.93 x 800. Ask 35.18 x 800. Day's Range 21.72 - 22.18. 52 Week Range 19.25 - 23.94. Volume 13,245. Avg. Volume 17,655. Market Cap (intraday) -- Beta (5Y Monthly) 0.53. PE Ratio...

    • News

      The latest news and headlines from Yahoo News. Get breaking...

    • Profile

      See the company profile for Public Storage (PSA-PI)...

    • Holders

      Find out the direct holders, institutional holders and...

    • Chart

      Loading Chart for PSA-PI . 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All ....

  4. radiologyassistant.nl › abdomen › prostateThe Radiology Assistant : Prostate Cancer - PI-RADS v2.1

    Aug 1, 2018 · Introduction. PI-RADS version 2.1. Peripheral zone. PI-RADS. Examples of PI-RADS 1-5. Prostate cancer in PZ. Transition Zone. PI-RADS. Examples of PI-RADS 1-5. Prostate cancer in TZ. Anterior Fibromuscular Stroma. TNM-stage. Locally advanced prostate cancer. N-stage. Benign findings. Benign prostate hyperplasia. Prostatitis. Hemorrhage. Cysts.

  5. People also ask

  6. www.pcf.org › about-prostate-cancer › diagnosisHow is Prostate Cancer Diagnosed? | Prostate Cancer Foundation

    Results will be reported as a PI-RADS score. PI-RADS 1: very low—clinically significant cancer is highly unlikely to be present; PI-RADS 2: low—clinically significant cancer is unlikely to be present; PI-RADS 3: intermediate—the chance of clinically significant cancer is neutral

    • 47 sec

  7. www.cancer.gov › types › prostateProstate-Specific Antigen (PSA) Test - NCI

    The PSA test is used to monitor men after surgery or radiation therapy for prostate cancer to see if their cancer has recurred (come back). If a man’s PSA level begins to rise after prostate cancer treatment, it may be the first sign of a recurrence.

  8. www.nature.com › articles › s41598/023/31869-1Predicting prostate cancer in men with PSA levels of 4–10 ng ...

    Mar 24, 2023 · To develop MRI-based radiomics model for predicting prostate cancer (PCa) in men with prostate-specific antigen (PSA) levels of 4–10 ng/mL, to compare the performance of radiomics model and...

  9. Videos

    View all

  10. www.nature.com › articles › s41391/022/00579-6The role of PSA density in the MRI pathway for prostate ...

    Jul 26, 2022 · On a per patient analysis, a PSAd cuttof of ≥0.1 ng/ml/cc improved csPCa detection by 7% for PI-RADS 3, 17% for PI-RADS 4 and 15% for PI-RADS 5. The author did not present or discuss...

  11. www.uptodate.com › contents › the-role-of-magneticThe role of magnetic resonance imaging in prostate cancer

    Dec 14, 2022 · Prostate imaging reporting and data system (PI-RADS) - Management of PI-RADS 3 lesions; CLINICAL APPLICATIONS. Elevated serum PSA with a prior negative TRUS biopsy; Initial presentation with no prior biopsy - Comparative data - Can any test predict who might benefit from prebiopsy MRI? - Should males with positive MRI scans only undergo ...